Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
This report contains market size and forecasts of Scopolamine in global, including the following market information:
Global Scopolamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Scopolamine Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Scopolamine companies in 2021 (%)
The global Scopolamine market was valued at 11 million in 2021 and is projected to reach US$ 15 million by 2028, at a CAGR of 4.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Scopolamine Butylbromide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Scopolamine include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation and Luyin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Scopolamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Scopolamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Scopolamine Market Segment Percentages, by Type, 2021 (%)
Scopolamine Butylbromide
Scopolamine Hydrobromide
Others
Global Scopolamine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Scopolamine Market Segment Percentages, by Application, 2021 (%)
Tablets
Injection
Patches
Global Scopolamine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Scopolamine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Scopolamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Scopolamine revenues share in global market, 2021 (%)
Key companies Scopolamine sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Scopolamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin